Showing results (261-270 of 424) with videos related to
Sort By:
Pageof 43
European Journal of Gastroenterology & Hepatology|May 1, 2002
Effect of terlipressin (Glypressin) on hepatorenal syndrome in cirrhotic patients: results of a multicentre pilot studyChantal Halimi, Philippe Bonnard, Brigitte Bernard, et al.Journal of Hepatology|November 9, 2005
Safety and efficacy of adefovir dipivoxil in patients infected with lamivudine-resistant hepatitis B and HIV-1Yves Benhamou, Vincent Thibault, Pamela Vig, et al.The Journal of Thoracic and Cardiovascular Surgery|March 11, 2008
Noninvasive assessment of liver fibrosis in patients with Fontan circulation using transient elastography and biochemical fibrosis markersMireen Friedrich-Rust, Constanze Koch, Axel Rentzsch, et al.Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|October 13, 2018
Performance of the SteatoTest, ActiTest, NashTest and FibroTest in a multiethnic cohort of patients with type 2 diabetes mellitusFernando Bril, Michael J McPhaul, Michael P Caulfield, et al.Journal of Hepatology|July 14, 2006
Diagnostic and predictive factors of significant liver fibrosis and minimal lesions in patients with persistent unexplained elevated transaminases. A prospective multicenter studyVictor de Lédinghen, Vlad Ratziu, Xavier Causse, et al.Journal of Hepatology|December 15, 2010
A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitisVlad Ratziu, Victor de Ledinghen, Fréderic Oberti, et al.Journal of Hepatology|November 6, 2021
EDP-305 in patients with NASH: A phase II double-blind placebo-controlled dose-ranging studyVlad Ratziu, Mary E Rinella, Brent A Neuschwander-Tetri, et al.Hepatology (Baltimore, Md.)|June 25, 2024
Aramchol improves hepatic fibrosis in metabolic dysfunction-associated steatohepatitis: Results of multimodality assessment using both conventional and digital pathologyVlad Ratziu, Yusuf Yilmaz, Don Lazas, et al.Obesity Surgery|December 31, 2024
Transjugular Intrahepatic Portosystemic Shunt (TIPS): A Bridge to Bariatric Surgery in Morbidly Obese Patients with Cirrhosis and Clinically Significant Portal HypertensionRaluca Pais, Yasmina Chouik, Lucile Moga, et al.Antimicrobial Agents and Chemotherapy|April 9, 2014
SILEN-C3, a phase 2 randomized trial with faldaprevir plus pegylated interferon α-2a and ribavirin in treatment-naive hepatitis C virus genotype 1-infected patientsDouglas Dieterich, Tarik Asselah, Dominique Guyader, et al.Pageof 43